0001209191-23-032350.txt : 20230525
0001209191-23-032350.hdr.sgml : 20230525
20230525210023
ACCESSION NUMBER: 0001209191-23-032350
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230523
FILED AS OF DATE: 20230525
DATE AS OF CHANGE: 20230525
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kiernan Jane E
CENTRAL INDEX KEY: 0001379171
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40355
FILM NUMBER: 23962753
MAIL ADDRESS:
STREET 1: 525 W ROSCOE
CITY: CHICAGO
STATE: IL
ZIP: 60657
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TREACE MEDICAL CONCEPTS, INC.
CENTRAL INDEX KEY: 0001630627
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 471052611
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 PALMETTO PARK PLACE
CITY: PONTE VEDRA
STATE: FL
ZIP: 32081
BUSINESS PHONE: (904) 373-5940
MAIL ADDRESS:
STREET 1: 100 PALMETTO PARK PLACE
CITY: PONTE VEDRA
STATE: FL
ZIP: 32081
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-23
0
0001630627
TREACE MEDICAL CONCEPTS, INC.
TMCI
0001379171
Kiernan Jane E
C/O TREACE MEDICAL CONCEPTS, INC.
100 PALMETTO PARK PLACE
PONTE VEDRA
FL
32081
1
0
0
0
0
Common Stock
2023-05-23
4
A
0
2753
0.00
A
5585
D
Stock Option (Right to Buy)
26.34
2023-05-23
4
A
0
6305
0.00
A
2033-05-23
Common Stock
6305
6305
D
Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer.
Includes 5,585 RSUs.
The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date.
/s/ Lisa Taylor as Attorney-in-fact for Jane Kiernan
2023-05-25